Dermal Filler Market Regional Analysis:
North American Market Insights
North America region is expected to account for more than 38.8% market share by 2035. The region’s leadership is backed by an economically stable population, along with a higher percentage of cosmetic surgeries in the region. The number of non-surgical cosmetic procedures in the U.S. was counted to be over 15.0 million in 2020, as per NLM. Another 2022 ISAPS statistic positioned the U.S. on top in performing aesthetic surgeries, accounting for 7.4 million. Moreover, the popularity of dermal fillers among the aging population and the rise in R&D expenditures are projected to fuel the market growth in the region.
Several driving factors in the U.S. present promising business opportunities for the market, such as aesthetic awareness, the aging population, increased personal income, and broad treatment options. As of June 2024, the nationwide personal income witnessed a monthly increment of USD 50.0 billion, where consumer spending increased by USD 57.6 billion: Bureau of Economic Analysis. The demography is inspiring domestic pioneers to expand their reach in this marketplace. For instance, in March 2024, Allergan Aesthetics attained FDA approval for marketing its hyaluronic acid (HA) dermal filler, JUVÉDERM VOLUMA XC injection, for use in the temple region.
APAC Market Insights
Asia Pacific is anticipated to register a remarkably fast CAGR in the dermal filler market during the forecast timeline. Technological advancements and rising exposure in dermatology are propelling this region’s progress. The lucrative trading environment is further attracting global leaders to participate in this landscape. For instance, in December 2024, Alma Lasers made its debut in APAC by launching its subsidiary in Thailand. The company previously attained marketing approval from the Thailand Food and Drug Administration (TFDA) for its Profhilo in April. The dermal bio-remodeler is used in remodeling laxity and supporting dermal tissue repair in acne scars.
India is propagating the market with its growing economy and expanding pharmaceutical industry. The increased disposal income of citizens in this country is influencing them to spend more on personal well-being, including their aesthetic desires. This is fostering a large consumer base for global and domestic pioneers. Following this opportunity, in September 2024, Menarini Group expanded its aesthetics portfolio, including Definisse Core Filler, in India. This international extension was a part of the company’s strategy to captivate greater cash flow by addressing the unique needs of the nation’s habitats.
